Q2 2026 13F · SEC CIK 1134283
Seizert Capital Partners, LLC
Institutional asset managerFiled 2026-08-05 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $2.4B
- Reported positions
- 181
- Top holdings a year, 3 yrs
- +16.2%
- Assets under management
- $2.5B
Seizert Capital Partners, LLC is an institutional asset manager that reported 181 positions worth $2.4B in its Q2 2026 13F, filed 2026-08-05. Its largest holdings were Match Group Inc New Com (MTCH, 3.3%), Netapp Inc (NTAP, 3.1%), Jpmorgan Chase & Co (JPM, 2.9%). A portfolio copying its top holdings returned 16.2% a year over the last 3 years, against 20.4% for the S&P 500.
Seizert Capital Partners, LLC holdings largest 50 of 181 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Seizert Capital Partners, LLC bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- META Meta Platforms Inc Class A+268.4% shares
- NBIX Neurocrine Biosciences Inc+216.4% shares
- PHM Pulte Group Inc+51.0% shares
- SNA Snap-on Inc.+40.6% shares
- LDOS Leidos Holdings Inc+40.1% shares
- CART Maplebear Inc.+31.5% shares
- BRK-B Berkshire Hathaway Inc Del+20.7% shares
- GHC Graham Holdings Co+19.5% shares
Reduced
- UTHR United Therapeutics Corp-26.6% shares
- QCOM Qualcomm Inc-17.8% shares
- REGN Regeneron Pharmaceuticals-16.9% shares
- UNH Unitedhealth Group Inc Com-15.7% shares
- AYI Acuity Brands Inc-12.9% shares
- LRCX Lam Research Corp-12.4% shares
- EXEL Exelixis Inc-9.2% shares
- BMY Bristol-Myers Squibb Co Com-8.5% shares
Left the top 50
- SIRI Sirius XMwas 2.0%
- DBX Dropbox Incwas 1.6%
- ACI Albertsons Cos Inc Comwas 1.4%
- FOXA Fox Corpwas 0.5%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +21.6% /yr
- S&P 500 +20.1%
- 3 years
- +16.2% /yr
- S&P 500 +20.4%
- 5 years
- +10.6% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $2.4B | 181 |
| Q1 2026 | $2.2B | 170 |
| Q4 2025 | $2.4B | 178 |
| Q3 2025 | $2.3B | 170 |
| Q2 2025 | $2.3B | 172 |
| Q1 2025 | $2.2B | 156 |
| Q4 2024 | $2.2B | 160 |
| Q3 2024 | $2.2B | 165 |
| Q2 2024 | $2.0B | 171 |
| Q1 2024 | $2.2B | 176 |
| Q4 2023 | $2.0B | 174 |
| Q3 2023 | $1.9B | 169 |
Questions about Seizert Capital Partners, LLC's portfolio
What stocks does Seizert Capital Partners, LLC own?
Seizert Capital Partners, LLC's latest 13F, for Q2 2026 and filed Aug 5, 2026, lists 181 positions worth $2.4B. The largest are Match Group Inc New Com (MTCH) at 3.3%, Netapp Inc (NTAP) at 3.1%, Jpmorgan Chase & Co (JPM) at 2.9%, Cisco Sys Inc (CSCO) at 2.9% and Qualcomm Inc (QCOM) at 2.7%.
What did Seizert Capital Partners, LLC buy last quarter?
In Q2 2026, Seizert Capital Partners, LLC added Meta Platforms Inc Class A (META) (+268.4% shares), Neurocrine Biosciences Inc (NBIX) (+216.4% shares) and Pulte Group Inc (PHM) (+51.0% shares), compared with its Q1 2026 filing.
What did Seizert Capital Partners, LLC sell last quarter?
In Q2 2026, Seizert Capital Partners, LLC cut from its top 50 Sirius XM (SIRI), cut from its top 50 Dropbox Inc (DBX), cut from its top 50 Albertsons Cos Inc Com (ACI), cut from its top 50 Fox Corp (FOXA), United Therapeutics Corp (UTHR) (-26.6% shares), Qualcomm Inc (QCOM) (-17.8% shares) and Regeneron Pharmaceuticals (REGN) (-16.9% shares), compared with its Q1 2026 filing.
How has Seizert Capital Partners, LLC's portfolio performed?
A portfolio copying Seizert Capital Partners, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +16.2% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +21.6% against +20.1%. Over 5 years: +10.6% a year against +11.6%.
When is Seizert Capital Partners, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Seizert Capital Partners, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Seizert Capital Partners, LLC manage?
Seizert Capital Partners, LLC reported $2.5B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $2.4B.